Quantum量子訊息有限公司
← 最新全球產業報告

U.S. Post-Surgical Scar Treatment Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-03-11 · 151 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 3,927.9 Mn
2033 年預估規模
USD 7,686.0 Mn
年複合成長率 CAGR
10.1%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-03-11頁數 151報告編號 CMI4955

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
U.S. Post-Surgical Scar Treatment Market, By Product Type (Silicone sheets & Patches, Surgical tapes, Strips, Gels & Creams, Others), By Channel (OTC, Rx), By Scar Type (Atrophic Scars, Hypertrophic Scars, Keloid Scars, Contracture Scars), By Surgery Type (Caesarean Section, Joint Replacement, Appendectomy, Heart Surgery, Breast surgery, Others), By End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals)

報告摘要

Any burn, injury, or trauma such as surgeries can cause a scar on the skin. Scarring is a natural healing process, which occurs after an injury. Its appearance and treatment depend on multiple factors such as the depth and size of the wound or the cut. It also depend upon the location of the wound, age, sex, and genes. There are various types of scars such as keloid scars, contracture scars, acne scars, and hypertrophic scars. Keloid scars are formed due to an over-aggressive healing process. They usually extend beyond their original location of the injury. Treatment of keloid scars include surgery, steroid injections, silicone sheets, and others. Hypertrophic scars are raised red scars and treatment of these scars include injection of steroids or silicone sheets. Market Dynamics Market players are engaged in inorganic growth activities such as acquisitions, and this is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, in April 2019, Merz, a company involved in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, an innovative U.S. consumer healthcare company, entered into an agreement to acquire the asset purchase agreement, according to which HRA Pharma will acquire the U.S. rights to the Mederma brand of Merz, which includes products across the scar care, stretch marks, and skincare categories. Moreover, in October 2019, 3M, a multinational conglomerate corporation operating in the fields of industry, worker safety, health care, and consumer goods, completed the acquisition of Acelity, Inc., a medical device company, to expand its surgical applications business, which include advanced wound care and specialty surgical applications marketed under the KCI brand (PROMOGRAN) in the developed economies such as the U.S. Key features of the study • This report provides an in-depth analysis of the U.S. post-surgical scar treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players • It profiles leading players in the U.S. post-surgical scar treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans • Key companies covered as a part of this study include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics • The U.S. post-surgical scar treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the U.S. post-surgical scar treatment market Market Segmentation • By Product Type o Silicone sheets & Patches o Surgical tapes o Strips o Gels & Creams o Others • By Channel o OTC o Rx • By Scar Type o Atrophic Scars o Hypertrophic Scars o Keloid Scars o Contracture Scars • By Surgery Type o Caesarean Section o Joint Replacement o Appendectomy o Heart Surgery o Breast surgery o Others • By End User o Ambulatory Surgical Centers o Clinics o Home Care Settings o Hospitals • Key Players o Smith & Nephew Plc. o 3M o Cardinal Health o Merz Pharma o Biodermis o Scar Heal, Inc. o Molnlycke Health Care AB o Implantech o Covalon Technologies Ltd. o Bio Med Sciences o Polymer Science, Inc. o Neodyne Biosciences, Inc.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Product Type  Market Snippet, By Channel  Market Snippet, By Scar Type  Market Snippet, By Surgery Type  Market Snippet, By End User o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Industry Trends o Regulatory Scenario o Acquisitions, Partnerships & Agreements o Brand Analysis o Pricing Analysis o Epidemiology o Porter’s Analysis o Number of Surgeries o Value Chain Analysis o Supply Chain Analysis o Distribution Landscape 4. U.S. Post-Surgical Scar Treatment Market, By Product Type, 2026 - 2033 (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 - 2033  Segment Trends o Silicone sheets & Patches  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Surgical tapes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Strips  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Gels & Creams  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) 5. U.S. Post-Surgical Scar Treatment Market, By Channel, 2026 - 2033 (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 - 2033  Segment Trends o OTC  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Rx  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) 6. U.S. Post-Surgical Scar Treatment Market, By Scar Type, 2026 - 2033 (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 - 2033  Segment Trends o Atrophic Scars  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Hypertrophic Scars  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Keloid Scars  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Contracture Scars  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) 7. U.S. Post-Surgical Scar Treatment Market, By Surgery Type, 2026 - 2033 (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 - 2033  Segment Trends o Caesarean Section  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Joint Replacement  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Appendectomy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Heart Surgery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Breast surgery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) 8. U.S. Post-Surgical Scar Treatment Market, By End User, 2026 - 2033 (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 - 2033  Segment Trends o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Home Care Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn) 9. Competitive Landscape o Company Profiles  Smith & Nephew Plc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  3M o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Cardinal Health Pfizer Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Merz Pharma o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Biodermis o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Scar Heal, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Molnlycke Health Care AB o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Implantech o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Covalon Technologies Ltd. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Bio Med Sciences o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Polymer Science, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies  Neodyne Biosciences, Inc. o Company Overview o Product Portfolio o Financial Performance o Recent Developments/Updates o Strategies 10. Section o Research Methodology o About us o Contact

提及公司

Smith & Nephew Plc.3MCardinal HealthMerz PharmaBiodermisScar Heal, Inc.Molnlycke Health Care ABImplantechCovalon Technologies Ltd.Bio Med SciencesPolymer Science, Inc.Neodyne Biosciences, Inc.

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們